To access this element change to forms mode OFF
Grant Award View - GA166500
A prospective, multicentre, randomised, blinded, two-arm parallel trial...
GA ID:
GA166500
Agency:
Department of Health and Aged Care
Approval Date:
27-Apr-2021
Publish Date:
25-May-2021
Category:
Health and Medical Research
Grant Term:
1-Jun-2021 to 31-May-2024
Value (AUD):
$692,016.90
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_EPCDR_Medicinal_Cannabis_Clinical_Trials
Grant Activity:
A prospective, multicentre, randomised, blinded, two-arm parallel trial of Medicinal Cannabis Products for alleviating symptom burden in children with advanced cancer
Purpose:
We aim to investigate if giving medicinal cannabis (MC) to children receiving palliative care for advanced cancer, improves their symptoms such as pain. A prospective, randomised trial will assess the effectiveness, safe doses and side-effects of two (MC) products. We will also ask children and parents about their views on MC cannabis use. This study will contribute to the limited evidence around the role and safe use of MC in children, which can be used to inform future clinical trials.
GO ID:
GO Title:
MRFF – Emerging Priorities and Consumer Driven Research – 2020 Medicinal Cannabis Clinical Trials Grant Opportunity
Internal Reference ID:
MRF2006342
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Queensland University of Technology
Recipient ABN:
83 791 724 622
Grant Recipient Location
Suburb:
Brisbane City
Town/City:
Brisbane City
Postcode:
4000
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, QLD
Postcode:
Multiple
Country:
AUSTRALIA